Business Description
Quest Laboratories Ltd
ISIN : INE0TNW01017
Total Employee Number:
50Description
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.68 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.38 | |||||
Interest Coverage | 9.4 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.61 | |||||
Beneish M-Score | -0.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.8 | |||||
3-Year EBITDA Growth Rate | -44.6 | |||||
3-Year EPS without NRI Growth Rate | 25.3 | |||||
3-Year Book Growth Rate | 85.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.51 | |||||
9-Day RSI | 42.92 | |||||
14-Day RSI | 43.33 | |||||
3-1 Month Momentum % | -35.6 | |||||
6-1 Month Momentum % | -11.96 | |||||
12-1 Month Momentum % | -11.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.31 | |||||
Quick Ratio | 4.23 | |||||
Cash Ratio | 1.06 | |||||
Days Inventory | 124.79 | |||||
Days Sales Outstanding | 104.84 | |||||
Days Payable | 27.94 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.77 | |||||
Operating Margin % | 15.58 | |||||
Net Margin % | 13.43 | |||||
EBITDA Margin % | 18.59 | |||||
FCF Margin % | -14.28 | |||||
OCF Margin % | -9.58 | |||||
ROE % | 16.78 | |||||
ROA % | 12.27 | |||||
ROIC % | 18.72 | |||||
3-Year ROIIC % | 12.13 | |||||
ROC (Joel Greenblatt) % | 27.25 | |||||
ROCE % | 21.74 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.79 | |||||
PE Ratio without NRI | 9.79 | |||||
PEG Ratio | 0.19 | |||||
PS Ratio | 1.32 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.52 | |||||
EV-to-EBIT | 7.1 | |||||
EV-to-EBITDA | 6.82 | |||||
EV-to-Revenue | 1.27 | |||||
EV-to-FCF | -8.87 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.39 | |||||
Price-to-Graham-Number | 0.81 | |||||
| Price-to-Net-Current-Asset-Value | 1.91 | |||||
Earnings Yield (Greenblatt) % | 14.08 | |||||
FCF Yield % | -10.86 | |||||
Forward Rate of Return (Yacktman) % | 17.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quest Laboratories Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,118.218 | ||
| EPS (TTM) (₹) | 9.16 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 69.75 | ||
| 14-Day RSI | 43.33 | ||
| 14-Day ATR (₹) | 4.062877 | ||
| 20-Day SMA (₹) | 92.49 | ||
| 12-1 Month Momentum % | -11.91 | ||
| 52-Week Range (₹) | 84 - 152.6 | ||
| Shares Outstanding (Mil) | 16.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quest Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quest Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quest Laboratories Ltd Frequently Asked Questions
What is Quest Laboratories Ltd(NSE:QUESTLAB)'s stock price today?
The current price of NSE:QUESTLAB is ₹89.70. The 52 week high of NSE:QUESTLAB is ₹152.60 and 52 week low is ₹84.00.
When is next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB)?
The next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB) is .
Does Quest Laboratories Ltd(NSE:QUESTLAB) pay dividends? If so, how much?
Quest Laboratories Ltd(NSE:QUESTLAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Quest Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers